Evaluation of the Ebola Vaccine's Acceptance Among Sub-Saharan African Communities: A Systematic Review and Meta-Analysis - Takeaways - MDSpire

Evaluation of the Ebola Vaccine's Acceptance Among Sub-Saharan African Communities: A Systematic Review and Meta-Analysis

  • By

  • Beni Matangi

  • Placide Matondo

  • Brandon Kayembe

  • Axel Okolo

  • Dieudonné Tawaba

  • Amede Kinuka

  • Donat Mangala

  • Ossam Odio

  • Nadine Mayasi

  • Tuna Lukiana

  • Madone Mandina

  • Taylor Pindi

  • Murielle Longokolo

  • Marcel Mbula

  • Hippolyte Situakibanza

  • Ben Bepouka

  • February 6, 2026

  • 0 min

Share

  • 1

    Ebola virus disease has a high case-fatality rate and significant epidemic potential, necessitating effective vaccination strategies.

  • 2

    Vaccine hesitancy remains a major barrier to achieving optimal Ebola vaccine coverage in sub-Saharan Africa.

  • 3

    The study aims to estimate Ebola vaccine acceptability and identify determinants among populations in sub-Saharan Africa.

  • 4

    The systematic review utilized the WHO's '3Cs' model, focusing on confidence, complacency, and convenience as key factors.

  • 5

    Findings from this review are intended to inform targeted public health interventions to improve vaccination coverage.

Original Source(s)

Evaluation of the Ebola Vaccine's Acceptance Among Sub-Saharan African Communities: A Systematic Review and Meta-Analysis

  • by Beni Matangi, Placide Matondo, Brandon Kayembe, Axel Okolo, Dieudonné Tawaba, Amede Kinuka, Donat Mangala, Ossam Odio, Nadine Mayasi, Tuna Lukiana, Madone Mandina, Taylor Pindi, Murielle Longokolo, Marcel Mbula, Hippolyte Situakibanza, Ben Bepouka

  • February 6, 2026

Related Content

Commentary: The effects of postponing BCG vaccination on the risk of BCG-related complications among patients with severe combined immunodeficiency disease in Saudi Arabia

Ebola at the World Cup? Here’s what we should actually worry about

Sustaining herd immunity against measles: Insights from a serological cohort study in an outbreak-free population